SCHEMBL14633008

SCHEMBL14633008

Cc1nn(-c2c(Cl)cccc2Cl)c(=O)c2cnc(Nc3ccc4c(c3)CCN(S(C)(=O)=O)C4)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WEE1 P30291 12/20 0.49
▸ CHEK1 O14757 2/20 0.48
▸ FLT3 P36888 2/20 0.48
▸ AURKA O14965 1/20 0.48
▸ RPS6KA5 O75582 1/20 0.48
▸ RPS6KA4 O75676 1/20 0.48
▸ KIT P10721 1/20 0.48
▸ RPS6KB1 P23443 1/20 0.48
▸ CDK2 P24941 1/20 0.48
▸ RPS6KA3 P51812 1/20 0.48
▸ RPS6KA2 Q15349 1/20 0.48
▸ RPS6KA1 Q15418 1/20 0.48
▸ IRAK4 Q9NWZ3 1/20 0.48
▸ RPS6KB2 Q9UBS0 1/20 0.48
▸ RPS6KA6 Q9UK32 1/20 0.48
▸ BTK Q06187 4/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ JAK3 P52333 3/20 0.45
▸ EGFR P00533 1/20 0.45
▸ JAK2 O60674 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14633114 0.91 WEE1 (0.49) WEE1BTKCYP3A4JAK3EGFR
SCHEMBL14633598 0.90 WEE1 (0.57) WEE1BTKCYP3A4
SCHEMBL14633190 0.88 WEE1 (0.62) WEE1CYP3A4
SCHEMBL14633050 0.87 WEE1 (0.58) WEE1BTKCYP3A4
SCHEMBL14633248 0.87 WEE1 (0.53) WEE1BTKCYP3A4
SCHEMBL14633582 0.87 BTK (0.61) WEE1CHEK1FLT3KITBTK
SCHEMBL14632907 0.86 WEE1 (0.58) WEE1BTKCYP3A4
SCHEMBL14633279 0.84 BTK (0.51) WEE1CHEK1FLT3KITBTK
SCHEMBL14632860 0.83 WEE1 (0.54) WEE1BTKCYP3A4
SCHEMBL14632939 0.83 WEE1 (0.62) WEE1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051327-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2015-06-09 — — US claimed
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBVIE INC (US) 2014-10-02 — — US claimed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO claimed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US claimed
US-9051327-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2015-06-09 — — US disclosed
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBVIE INC (US) 2014-10-02 — — US disclosed
US-8796289-B2 Pyridazino[4,5-D]pyrimidin-5(6H)-one inhibitors of kinases ABBVIE INC. (US) 2014-08-05 — — US disclosed
WO-2013013031-A1 PYRIDAZINO [4, 5 -D] PYRIMIDIN- (6H) -ONE INHIBITORS OF WEE - 1 KINASE ABBVIE INC. (US) 2013-01-24 — — WO disclosed
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES ABBOTT LABORATORIES (US) 2013-01-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296220-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885CHEK1 68/4885FLT3 269/4885
US-20130023523-A1 PYRIDAZINO[4,5-D]PYRIMIDIN-5(6H)-ONE INHIBITORS OF KINASES WEE1, WEE2, CDK1 WEE1 1/4885CHEK1 68/4885FLT3 269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback